fr

CARMAT announces the first commercial implants of its Aeson® artificial heart outside the European Union

CARMAT has begun, with DEKRA, the CE certification process for its bioprosthetic artificial heart

Download

Professor Carpentier finalist for the European Inventor Award 2016

Download

CARMAT completes its €50.0m reserved capital increase

Download

CARMAT to participate in the 36th ISHLT annual meeting in Washington DC

Download

Approval of the resolutions pertaining to the reserved capital increase and the Group's governance

Download

€50M Equity Financing to Reinforce CARMAT’s Cash Resources

Download

2015 annual results

Download

Information regarding the Feasibility study of the CARMAT bioprosthetic artificial heart

Download
Top of page